Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma (Q24648832)
Jump to navigation
Jump to search
scientific article
- Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma
Language | Label | Description | Also known as |
---|---|---|---|
English | Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma |
scientific article |
|
Statements
Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma (English)
0 references
2008
0 references
8
0 references
1
0 references
205
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference